Endocrine Disruptors in the Environment

Author: Sushil K. Khetan  

Publisher: John Wiley & Sons Inc‎

Publication year: 2014

E-ISBN: 9781118891032

P-ISBN(Paperback): 9781118852934

P-ISBN(Hardback):  9781118852934

Subject: R58 Endocrine disease and metabolic disease

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

A concise and engaging overview of endocrine disruption phenomena that brings complex concepts within the reach of non-specialists

For most of the last decade, the science of endocrine disruption has evolved with more definitive evidence of its damaging potential to health and environment. This book lists the major environmental chemicals of concern and their mechanism of endocrine disruption including remedial measures for them.

Divided into three parts, Endocrine Disruptors in the Environment begins with an overview of the endocrine system and endocrine disruptors, discussing their salient features and presenting a historical perspective of endocrine disruption phenomena. It then goes on to cover hormone-signaling mechanisms, followed by various broad classes of putative endocrine disruptors, before introducing readers to environmental epigenetic modifications. Part two of the book focuses on removal processes of various EDCs by biotic and abiotic transformation/degradation. The last section consists of four chapters embracing themes on finding solutions to environmental EDCs—including their detection, regulation, replacement, and remediation.

Endocrine Disruptors in the Environment is the first book to detail the endocrine effects of several known environmental contaminants and their mechanism of endocrine disruption. Additionally, it:

  • Covers both the chemistry and biology of endocrine disruption and compiles almost all the known endocrine disrupting environmental chemicals and their mechanisms of toxicity
  • Addresses policy and regulatory issues relevant to EDCs including scientific uncertainty and precautionary policy
  • Brings forth the use of Green Chemistry principles in avoiding endocrine disruption in the designing and screening for safer chemicals and remediation of the EDCs in aquatic environment
  • Includes a useful glossary of technical terms, a list of acronyms, topical references, and a subject index

Endocrine Disruptors in the Environment is an ideal book for environmental chemists and endocrine toxicologists, developmental biologists, endocrinologists, epidemiologists, environmental health scientists and advocates, and regulatory officials tasked with risk assessment in environment and health areas.

Chapter

Chapter 1 Environmental Endocrine Disruptors

1.1 Introduction

1.1.1 The Endocrine System

1.1.2 Endocrine Disrupting Chemicals (EDCs)

1.1.3 Sources of EDCs in the Environment

1.1.4 Deleterious Effects of EDCs on Wildlife and on Humans

1.1.5 Endocrine Disruption Endpoints

1.2 Salient Aspects about Endocrine Disruption

1.2.1 Low-Dose Effects and Nonmonotonic Dose Responses

1.2.2 Exposures during Periods of Heightened Susceptibility in Critical Life Stages

1.2.3 Delayed Dysfunction

1.2.4 Importance of Mixtures

1.2.5 Transgenerational, Epigenetic Effects

1.3 Historical Perspective of Endocrine Disruption

1.4 Scope and Layout of this Book

1.5 Conclusion

References

Part I Mechanisms of Hormonal Action and Putative Endocrine Disruptors

Chapter 2 Mechanisms of Endocrine System Function

2.1 Introduction

2.2 Hormonal Axes

2.2.1 Hypothalamus-Pituitary-Gonad (HPG) Axis

2.2.2 The Hypothalamic-Pituitary-Thyroid (HPT) Axis

2.2.3 The Hypothalamic-Pituitary-Adrenal (HPA) Axis

2.3 Hormonal Cell Signaling

2.3.1 Receptors and Hormone Action

2.3.2 Genomic Signaling Pathway

2.3.3 Rapid-Response Pathway (Nongenomic Signaling)

2.3.4 Receptor Agonists, Partial Agonists, and Antagonists

2.4 Sex Steroids

2.4.1 Physiologic Estrogens

2.4.2 Androgens

2.5 Thyroid Hormones

2.6 Conclusions and Future Prospects

References

Chapter 3 Environmental Chemicals Targeting Estrogen Signaling Pathways

3.1 Introduction

3.1.1 Gonadal Estrogen Function Disruptors

3.2 Steroidal Estrogens

3.2.1 Physiologic Estrogens

3.2.2 17alpha-Ethinylestradiol (EE2)

3.2.3 Phytoestrogens

3.2.4 Mycoestrogen-Zearalenone (ZEN)

3.3 Nonsteroidal Estrogenic Chemicals

3.3.1 Diethylstilbestrol (DES)

3.3.2 Organochlorine Insecticides

3.3.3 Polychlorinated Biphenyls (PCBs)

3.3.4 Alkyphenols

3.3.5 Parabens (Hydroxy Benzoates)

3.3.6 Sun Screens (Chemical UV Filters)

3.4 Metalloestrogens

3.4.1 Cadmium (Cd)

3.4.2 Lead (Pb)

3.4.3 Mercury (Hg)

3.4.4 Arsenic (As)

3.5 Conclusion and Future Prospects

References

Chapter 4 Anti-Androgenic Chemicals

4.1 Introduction

4.2 Testosterone Synthesis Inhibitors

4.2.1 Phthalates

4.3 Androgen Receptor (AR) Antagonists

4.3.1 Organochlorine (OC) Pesticides

4.3.2 Organophosphorus (OP) Insecticides

4.3.3 Bisphenol A (BPA)

4.3.4 Polybrominated Diphenyl Ethers (PBDEs)

4.3.5 Vinclozolin (VZ)

4.3.6 Procymidone

4.4 AR Antagonists and Fetal Testosterone Synthesis Inhibitors

4.4.1 Prochloraz

4.4.2 Linuron

4.5 Comparative Anti-Androgenic Effects of Pesticides to Androgen Agonist DHT

4.6 Conclusions and Future Prospects

References

Chapter 5 Thyroid-Disrupting Chemicals

5.1 Introduction

5.2 Thyroid Synthesis Inhibition by Interference in Iodide Uptake

5.2.1 Perchlorate

5.3 TH Transport Disruptors and Estrogen Sulfotransferases Inhibitors

5.3.1 Polychlorinated Biphenyls (PCBs)

5.3.2 Triclosan

5.4 Thyroid Hormone Level Disruptors

5.4.1 Polybrominated Diphenyl Ethers (PBDEs)

5.5 Selective Thyroid Hormone Antagonists

5.5.1 Bisphenols

5.5.2 Perfluoroalkyl Acids (PFAAs)

5.5.3 Phthalates

5.6 Conclusions and Future Prospects

References

Chapter 6 Activators of PPAR, RXR, AhR, and Steroidogenic Factor 1

6.1 Introduction

6.2 Peroxisome Proliferator-Activated Receptor (PPAR) Agonists

6.2.1 Organotin Antifoulant Biocides

6.2.2 Perfluoroalkyl Compounds (PFCs)

6.2.3 Phthalates

6.3 Aryl Hydrocarbon Receptor (AhR) Agonists

6.3.1 Polychlorinated-Dibenzodioxins (PCDDs) and -Dibenzofurans (PCDFs)

6.3.2 Coplanar Polychlorinated Biphenyls

6.3.3 Substituted Urea and Anilide Herbicides

6.4 Steroidogenesis Modulator (Aromatase Expression Inducer)

6.4.1 Atrazine

6.5 Conclusions and Future Prospects

References

Chapter 7 Effects of EDC Mixtures

7.1 Introduction

7.2 Combined Effect of Exposure to Multiple Chemicals

7.3 Mixture Effects of Estrogenic Chemicals

7.4 Mixture Effects of Estrogens and Anti-Estrogens

7.5 Mixture Effects of Anti-Androgens

7.5.1 Anti-Androgens with Common Mechanism of Action

7.5.2 Anti-Androgens with Different Modes of Action

7.5.3 Chronic Exposure of Low Dose Mixture of Anti-Androgens Versus Acute Exposure to High Dose Individual Compounds

7.6 Mixture Effects of Thyroid Disrupting Chemicals

7.7 Mixture Effects of Chemicals Acting via AhR

7.8 Conclusions and Future Prospects

References

Chapter 8 Environmentally Induced Epigenetic Modifications and Transgenerational Effects

8.1 Introduction

8.2 Regulatory Epigenetic Modifications

8.2.1 Methylation of Cytosine Residues in the DNA and Impact on Gene Expression (Transcriptional Silencing)

8.2.2 Remodeling of Chromatin Structure through Post-Translational Modifications of Histone Tails (Determinants of Accessibility)

8.2.3 Regulation of Gene Expression by Noncoding RNAs

8.2.4 DNA Demethylation

8.2.5 Assays for Epigenetic Modification

8.3 Epigenetic Dysregulation Effects of Endocrine Disruption

8.3.1 Bisphenol A (BPA): A Case Study

8.3.2 DEHP

8.4 Environmental Epigenetic Effects of Heavy Metals Exposure

8.4.1 Cadmium

8.4.2 Arsenic

8.4.3 Nickel

8.4.4 Lead

8.5 Transgenerational Inheritance of Environmentally Induced Epigenetic Alterations

8.5.1 DES

8.5.2 Vinclozolin

8.5.3 Methoxychlor

8.5.4 BPA

8.5.5 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)

8.6 Transgenerational Actions of EDCs Mixture on Reproductive Disease

8.7 Conclusions and Future Prospects

References

Part II Removal Mechanisms of EDC through Biotic and Abiotic Processes

Chapter 9 Biodegradations and Biotransformations of Selected Examples of EDCs

9.1 Introduction

9.2 Natural and Synthetic Steroidal Estrogens

9.2.1 17beta-Estradiol and Estrone

9.2.2 17alpha-Ethynylestradiol

9.3 Alkylphenols

9.3.1 4-n-Nonylphenol (4-NP1)

9.3.2 4-tert-Nonylphenol Isomer 4-(1-Ethyl-1,4-Eimethylpentyl) Phenol (NP112)

9.3.3 4-tert-Nonylphenol Isomer 4-[1-Ethyl-1,3-Dimethylpentyl] Phenol (4-NP111)

9.3.4 4-n- and 4-tert-Octylphenols

9.3.5 Bisphenol A

9.4 Phthalates

9.4.1 Di-n-butyl Phthalate (DBP)

9.4.2 n-Butyl Benzyl Phthalate (BBP)

9.4.3 Di-(2-ethylhexyl) Phthalate (DEHP)

9.4.4 Di-n-octyl Phthalate (DOP)

9.5 Insecticides

9.5.1 Methoxychlor

9.6 Fungicides

9.6.1 Vinclozolin

9.6.2 Procymidone

9.6.3 Prochloraz

9.7 Herbicides

9.7.1 Linuron

9.7.2 Atrazine

9.8 Polychlorinated Biphenyls (PCBs)

9.9 Polybrominated Diphenyl Ethers (PBDEs)

9.9.1 2,2',4,4'-Tetrabromodiphenyl Ether (BDE-47)

9.9.2 2,2',4,4',5-Penta-bromodiphenyl Ether (BDE-99)

9.9.3 3,3',4,4',5,5',6,6'-Decabromodiphenyl Ether (BDE-209)

9.10 Triclosan

9.11 Conclusions and Future Prospects

References

Chapter 10 Abiotic Degradations/Transformations of EDCs Through Oxidation Processes

10.1 Introduction

10.2 Natural and Synthetic Estrogens

10.2.1 17beta-Estradiol (E2) and Estrone (E1)

10.2.2 17alpha-Ethinylestradiol (EE2)

10.3 Bisphenol A

10.3.1 Chlorination with HOCl

10.3.2 Catalytic Oxidation with H2O2

10.3.3 Oxidation with KMnO4

10.3.4 Oxidation with MnO2

10.3.5 Treatment with Zero-Valent Aluminum

10.3.6 Ozonation

10.3.7 Fenton Reaction

10.3.8 Photolytic and Photocatalytic Degradation

10.4 4-Octylphenol and 4-Nonylphenol

10.4.1 Chlorination

10.4.2 Ozonation

10.4.3 Photocatalytic Degradation

10.5 Parabens

10.5.1 Ozonation

10.5.2 Photocatalytic Degradation

10.6 Phthalates-Photocatalytic Degradation

10.6.1 Dibutyl Phthalate (DBP)

10.6.2 n-Butyl Benzylphthalate

10.6.3 Di(2-Ethylhexyl)phthalate (DEHP)

10.7 Linuron

10.7.1 Treatment with O3, UV, and UV/O3

10.8 Atrazine

10.8.1 Fenton Reaction

10.8.2 Reaction with Ozone, Ozone/H2O2, and Ozone/OH Radicals

10.8.3 Treatment with delta-MnO2

10.8.4 Reductive Dechlorination

10.8.5 Photocatalytic Degradation

10.9 Polybrominated Diphenyl Ether (PBDE) Flame Retardants

10.9.1 Photochemical Degradation

10.9.2 TiO2-Mediated Photocatalytic Debromination

10.9.3 Zero-Valent Iron Reductive Debromination

10.10 Triclosan

10.10.1 Clorination with HOCl

10.10.2 Oxidation with KMnO4/MnO2

10.10.3 Ozonation

10.10.4 Photochemical Transformation

10.11 PFOA and PFOS

10.11.1 Modified Fenton Reaction

10.11.2 Sonochemical Degradation

10.11.3 Photocatalytic Reaction

10.12 Conclusions

References

Part III Screening and Testing for Potential EDC, Implications for Water Quality Sustainability, Policy and Regulatory Issues, and Green Chemistry Principles in the Design of Safe Chemicals and Remediation of EDC

Chapter 11 Screening and Testing Programs for EDCs

11.1 Introduction

11.2 Endocrine Disruptor Screening Program (EDSP)

11.2.1 EDSP Tier 1

11.2.2 EDSP Tier 2

11.3 Assays for the Detection of Chemicals that Alter the Estrogen Signaling Pathway

11.3.1 The ER Binding Assay (USEPA OPPTS 890.1250)

11.3.2 ERalpha Transcriptional Activation Assay (USEPA OPPTS 890.1300; OECD 455)

11.3.3 Aromatase Assay (USEPA OPPTS 890.1200)

11.3.4 In vivo Uterotrophic Bioassay in Rodents (USEPA OPPTS 890.1600; OECD 440)

11.3.5 Pubertal Female Rat Assay (USEPA OPPTS 890.1450)

11.3.6 Twenty-One-Day Fish Reproduction Assay (USEPA OPPTS 890.1350; OECD 229)

11.4 Assays for the Detection of Chemicals that Alter the Androgenic Signaling Pathway

11.4.1 AR Binding Assay (Rat Prostate Cytosol) (USEPA OPPTS 890.1150)

11.4.2 H295R Steroidogenesis Assay (USEPA OPPTS 890.1550)

11.4.3 Hershberger Bioassay in Rats for Androgenicity (USEPA OCSPP 890.1400; OECD 441)

11.4.4 Pubertal Male Rat Assay (USEPA OPPTS 890.1500)

11.4.5 Strengths and Limitations of Assays for Interference with Androgen Action

11.5 Assays for the Detection of Chemicals that Alter the HPT Axis

11.5.1 Amphibian Metamorphosis Assay (OPPTS 890.1100)

11.5.2 Strengths and Limitations of Thyroid Disrupting Chemical Assays

11.6 The USEPA's EDSP21 Work Plan

11.6.1 The USEPA ToxCast Program

11.6.2 Tox21 HTS Programs

11.7 Conclusions and Future Prospects

References

Chapter 12 Trace Contaminants: Implications for Water Quality Sustainability

12.1 Introduction

12.2 Trace Contaminants Sources in Water

12.3 Wastewater Reclamation Processes

12.3.1 Primary Treatment: Sedimentation/Coagulation

12.3.2 Secondary Treatment: Removal by Physical Methods or Biological Process

12.3.3 Tertiary Treatment: Redox Processes

12.4 Indirect Water Reuse Systems

12.4.1 Removal of Trace Contaminants for Potable Water Reuse Applications

12.5 Leaching of Contaminants in Water-the Case of Bottled Water

12.6 Water Quality Sustainability and Health Effects

12.7 Toxicological Implications

12.8 Regulatory Structures to Maintain Water Quality

12.9 Conclusions and Future Prospects

References

Chapter 13 Policy and Regulatory Considerations for EDCs

13.1 Introduction

13.2 Regulating Paradigm Shift in Conventional Toxicology

13.2.1 Downward Movement of Safe Thresholds

13.2.2 Nonmonotonic Low-Dose Effects (Nonthreshold substances)

13.2.3 Sensitivity of Development Periods

13.2.4 Cumulative Exposures to Multiple EDCs (Exposures can be Additive)

13.2.5 Long Latency Between Exposure and Effect (Delayed Effects)

13.3 Policy Options for EDC Regulation

13.3.1 Scientific Uncertainty and Precautionary Policy

13.3.2 Shifting the Burden of Proving Safe Products

13.3.3 Need to Broaden the Risk Assessment

13.3.4 Cutting-Edge Bioassays Showing Developmental Endpoints

13.4 Controversy on Regulatory Framework for EDCs

13.4.1 Diversity of Viewpoints of the Risk Assessors and the Endocrine Scientists

13.4.2 A Debate on EU Regulatory Framework for EDCs

13.5 Conclusions and Future Prospects

References

Chapter 14 Green Chemistry Principles in the Designing and Screening for Safe Chemicals and Remediation of EDCs

14.1 Introduction

14.2 Benign by Design Chemicals

14.3 Chemical Endocrine Disruption Screening Protocol

14.3.1 Tiered Protocol for Endocrine Disruption

14.4 Green Oxidative Remediation of EDCs

14.4.1 Catalytic Oxidation Processes

14.5 Conclusions and Future Prospects

References

Index

The users who browse this book also browse